Goldman Steven Harold 4
4 · STELLAR PHARMACEUTICALS INC · Filed Aug 31, 2012
Insider Transaction Report
Form 4
Goldman Steven Harold
Director
Transactions
- Purchase
Common Shares
2012-08-31$0.46/sh+15,000$6,900→ 980,146 total(indirect: Lambent Consulting Corp) - Purchase
Common Shares
2012-08-31$0.49/sh+5,000$2,445→ 985,146 total(indirect: Lambent Consulting Corp) - Purchase
Common Shares
2012-08-31$0.49/sh+15,000$7,350→ 1,000,146 total(indirect: Lambent Consulting Corp)